First report of Barley Yellow Dwarf Viruses (BYDVs) on dicotyledonous weed hosts in Turkey

Yellow dwarf viruses (YDVs) are economically destructive viral diseases of cereal crops, which cause the reduction of harvested yield and quality of grains. Up to now the identification of such viruses was limited to monocotyledonous Poaceae weed hosts, and was not investigated in dicotyledons. In this study, using DAS-ELISA and RT-PCR methods, 6 dicotyledonous weed species, collected from Trakya, Turkey, were examined for the presence of the YDVs pathogens BYDV-PAV, BYDV-MAV, BYDV-RMV, BYDV-SGV and CYDV-RPV. The screening tests revealed certain samples of Geranium dissectum L. and Juncus compressus Jacq. were infected with BYDV-PAV, while other samples of the same species were positive for BYDV-MAV. Additionally, RT-PCR tests of both weed species revealed cases of mixed infection by BYDV-PAV and BYDV-MAV. Transmission experiments using the aphid species Rhopalosiphum padi L. showed that BYDV-PAV was transmitted persistently from Geranium dissectum to barley cv. Barbaros seedlings. To our knowledge, this is the first report of Geranium dissectum and Juncus compressus as possible plant hosts of BYDV-PAV and BYDV-MAV in Turkey

SARcopenia Assessment in Hypertension: The SARAH Study.

© 2022 Wolters Kluwer Health, Inc.Objectives: The aims of the study were to investigate the relationship between sarcopenia and renin-angiotensin system-related disorders and to explore the effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on muscle mass/function and physical performance. Design: This multicenter, cross-sectional study was performed using ISarcoPRM algorithm for the diagnosis of sarcopenia. Results: Of the 2613 participants (mean age = 61.0 ± 9.5 yrs), 1775 (67.9%) were hypertensive. All sarcopenia-related parameters (except chair stand test in males) were worse in hypertensive group than in normotensive group (all P < 0.05). When clinical/potential confounders were adjusted, hypertension was found to be an independent predictor of sarcopenia in males (odds ratio = 2.403 [95% confidence interval = 1.514-3.813]) and females (odds ratio = 1.906 [95% confidence interval = 1.328-2.734], both P < 0.001). After adjusting for confounding factors, we found that all sarcopenia-related parameters (except grip strength and chair stand test in males) were independently/negatively related to hypertension (all P < 0.05). In females, angiotensin-converting enzyme inhibitors users had higher grip strength and chair stand test performance values but had lower anterior thigh muscle thickness and gait speed values, as compared with those using angiotensin II receptor blockers (all P < 0.05). Conclusions: Hypertension was associated with increased risk of sarcopenia at least 2 times. Among antihypertensives, while angiotensin-converting enzyme inhibitors had higher muscle function values, angiotensin II receptor blockers had higher muscle mass and physical performance values only in females